Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of febrile events during hematopoietic progenitor cell apheresis in multiple myeloma
2005-004885-18Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Apr 2006
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of lenograstim and filgrastim in multiple myeloma (MM) (2 arms), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Incidence of febrile events in both treatment arms. Started Apr 2006; status: active.
02
Drugs
lenograstimfilgrastim
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2005-004885-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004885-18.